Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study with Inhaled RVT-1601 for the Treatment of Persistent Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF): SCENIC Trial

  • Glaspole, Ian (Primary Chief Investigator (PCI))
  • Symons, Karen M. (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date22/11/19 → 30/11/21

Keywords

  • Respiratory medicine
  • Idiopathic pulmonary fibrosis
  • Clinical trial